Dyskinesias
Dermatology·MeSH: Dyskinesias
Prevalence
30.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Frequently asked questions
How many drugs are in development for Dyskinesias?
BioSniper tracks 1 drug in development for Dyskinesias across 1 company.
How many clinical trials target Dyskinesias?
There are 3 clinical trials targeting Dyskinesias tracked by BioSniper.
What is the prevalence of Dyskinesias?
The estimated prevalence of Dyskinesias is approximately 30.0 per 100,000 population.
Deep-dive into Dyskinesias
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis